1.Multi-slice spiral CT manifestations of portal vein cavernous transformation secondary to tumor emboli from hepatocellular carcinoma
Yongdong ZHU ; Qinglian WANG ; Yubao LIU ; Changhong LIANG ; Shuixing ZHANG
Chinese Journal of Interventional Imaging and Therapy 2010;7(1):31-34
Objective To observe the multi-slice spiral CT manifestations of cavernous transformation of the portal vein (CTPV) secondary to tumor emboli from hepatocellular carcinoma (HCC). Methods MSCT manifestations of 31 patients of HCC with tumor emboli-induced CTPV proved by operation and pathology were collected and the data were retrospectively analyzed. Results Tumor embolus was detected in both the trunk, left and right branches of PV in 23 patients, accompanied with superior mesenteric vein and/or splenic vein and inferior vena cava's tumor embolus in 4 and infiltration of gallbladder in 1 of 23 patients, as well as in the trunk and left branch in 1, and in the trunk and right branch of PV in 5 patients, accompanied with right hepatic vein and/or inferior vena cava's tumor embolus in 2 and in the portal trunk and superior mesenteric vein in 1, only in the right branch in 1 patient, respectively. Tumor emboli were isodense in plain CT scan, but enhanced with obvious degrees in arterial phase and filling defects in portal venous phase. There were collateral vessels around portal vein. Lateral branches around hilar bile duct, the open of venous plexus around fossa of gallbladder, lateral veins around gastric fundus and lesser curvature, lateral veins of lower part of esophagus and expansion of splenic vein were found in 31 (100%), 19 (61.29%), 21 (67.74%), 7 (22.58%) and 15 patients (48.38%), respectively. Conclusion Tumor emboli-induced CTPV from HCC has specific MSCT findings being helpful to the diagnosis.
2.Effects of Lidocaine on Respiratory Failure and the Airway Peak Pressure in Patients with Severe Asthma: A Clinical Research
Chenghui WANG ; Huan LIU ; Qinglian WU ; Biyun HE ; Jingjie LIAO
China Pharmacy 2001;0(10):-
OBJECTIVE: To observe the effect of lidocaine on respiratory failure and the airway peak pressure in patients with severe asthma. METHODS: The severe bronchial asthma patients treated with mechanical ventilation were randomly divided into treatment group and control group. The change in airway peak pressure, man-machine counteraction, and the correcting time of respiratory failure of the two groups were recorded. RESULTS: The average airway peak pressure was(41.18?10.66) cmH2O in the control group vs.(29.23?9.07) cmH2O in the treatment group; the incidence of man-machine counteraction was 100% for the control group vs. only 40% for the treatment group; the correcting time of respiratory failure was(6.42?1.73) h for the control group vs.(3.31?1.08) h for the treatment group. There were significant differences between the two groups in the above mentioned indexes(P
3.Isolation and purification of alpha-glycerophosphate oxidase in a polyethylene glycol/(NH4 )2SO4 aqueous two-phase system.
Yao MENG ; Jiagui JIN ; Shuangfeng LIU ; Min YANG ; Qinglian ZHANG ; Li WAN ; Kun TANG
Journal of Biomedical Engineering 2014;31(1):136-141
Alpha-glycerophosphate oxidase (alpha-GPO) from Enterococcus casseli flavus was successfully isolated and purified by using polyethylene glycol (PEG)/(NH4)2SO4 aqueous two-phase system (ATPS). The results showed that the chosen PEG/(NH4)2SO4 ATPS could be affected by PEG molecular weight, pH, concentration of PEG and (NH4)2SO4, and inorganic salt as well as additional amount of crude enzyme. After evaluating these influencing factors, the final optimum purification strategy was formed by 16.5% (m/m) PEG2000, 13.2% (m/m) (NH4)2SO4, pH 7.5 and 30% (m/m) additive crude enzyme, respectively. The NaCl was a negative influencing factor which would lead to lower purification fold and activity recovery. These conditions eventually resulted in the activity recovery of 89% (m/m), distribution coefficient of 1.2 and purification fold of 7.0.
Ammonium Sulfate
;
chemistry
;
Glycerolphosphate Dehydrogenase
;
chemistry
;
isolation & purification
;
Molecular Weight
;
Polyethylene Glycols
;
chemistry
;
Water
4.In vivo study of radiosensitization by Topotecan on nasopharyngeal carcinoma
Jingbo WU ; Qinglian WEN ; Juan FAN ; Jinyi LANG ; Yanping WANG ; Xuexu LIU
Chinese Archives of Otolaryngology-Head and Neck Surgery 2006;0(02):-
OBJECTIVE To study the radiose-nsitization by Topotecan on human nasopharyngeal carcinoma in nude mice. METHODS ①To study the maximum tolerance dose of TPT and detect the effective rate of TPT and RT on nude mice. ② Plan of radiosensitization practice:53 nude mice xenografts were distributed to 5 groups:RT 20 Gy group,RT 40 Gy group,TPT 12.5 mg/kg group,TPT 12.5 mg/kg+RT 20 Gy group and the controlgroup. After treatment,the volume of tumors were measured every 3 days in order to value the effective rate [complete remission(CR) + partial remission(PR) ]and regrowth delay time(TGD) and to fit the growth curve. RESULTS This study showed that the effective rates had significant difference among RT20 Gy+TPT 12.5 mg/kg group,RT20 Gy group and TPT12.5 mg/kg group,while that of RT20 Gy +TPT 12.5 mg/kg group and RT40 Gy group had no statistical difference. SER reached to 1.34. CONCLUSION Topotecan has been shown a radiosensitizing effect on human nasopharyngeal carcinoma in vivo.
5.Effects of microfilaments on the expression of collagenases and tissue inhibitor of metalloproteinases-1 in fibroblasts.
Haifeng GU ; Qinglian HE ; Zihao LIN ; Qi LIU ; Xingmei ZHANG
Chinese Journal of Plastic Surgery 2002;18(3):163-164
OBJECTIVETo investigate the roles of microfilaments in the expression of collagenase and TIMP-1 in normal and hypertrophic scar.
METHODSCell culture and Northern blot hybridization methods were used in this study.
RESULTSAfter the disruption of microfilaments with cytochalasin B, mRNA contents of collagenase and TIMP-1 both increased significantly in normal and hypertrophic scar fibroblasts.
CONCLUSIONThe result suggest that the microfilament cytoskeleton may regulate the synthesis and degradation of ECM, which may be a mechanism of gene regulation during wound healing.
Actin Cytoskeleton ; physiology ; Cells, Cultured ; Collagenases ; genetics ; Fibroblasts ; metabolism ; Humans ; RNA, Messenger ; analysis ; Tissue Inhibitor of Metalloproteinase-1 ; genetics ; Wound Healing ; physiology
6.Analysis of clinical phenotype and gene variants in a patient with classic tuberous sclerosis complex
Linli LIU ; Gaowu YAN ; Lingli DENG ; Qinglian LU ; Tingting LIU ; Fei OUYANG ; Chunshui YU
Chinese Journal of Dermatology 2022;55(8):713-716
Objective:To analyze clinical phenotypes and pathogenic mutations of a patient with classic tuberous sclerosis complex.Methods:Clinical data was collected from a patient with classic tuberous sclerosis complex. Next-generation sequencing was performed to screen pathogenic gene variants, and Sanger sequencing to verify the mutations. Minigene plasmids were constructed and transfected into the human renal epithelial cell line 293T, and RNA was extracted for transcriptional analysis.Results:The patient clinically presented with recurrent epileptic seizures, facial angiofibroma, periungual fibroma, pulmonary lymphangioleiomyomatosis, renal angiomyolipoma and multiple osteosclerosis. Next-generation sequencing revealed a suspected pathogenic variant in the TSC2 gene in the patient. Sanger sequencing identified a heterozygous mutation c.336_336+15delGGTAAGGCCCAGGGCG in exon 4 of the TSC2 gene in the patient, but not in his parents or 100 unrelated healthy controls. Moreover, this mutation had not been previously reported. The minigene experiment showed changed mRNA sequence of the TSC2 gene in this patient with loss of the authentic splice site in exon 4 and insertion of a 74-bp intron, which shifted the splice site 90 bp downstream (r.336delins336+16_336+90) .Conclusion:The novel heterozygous mutation c.336_336+15delGGTAAGGCCCAGGGCG in exon 4 of the TSC2 gene can lead to aberrant splicing, and may contribute to tuberous sclerosis complex in this patient.
7.Identification of a novel TSC2 gene variant in a patient with tuberous sclerosis complex.
Linli LIU ; Chunshui YU ; Herong YANG ; Qinglian LU ; Fei OUYANG ; Tingting LIU
Chinese Journal of Medical Genetics 2021;38(9):877-879
OBJECTIVE:
To explore the genetic basis for a patient diagnosed with tuberous sclerosis complex (TSC).
METHODS:
Peripheral blood samples of the patient and his parents were collected for the extraction of genomic DNA. Next generation sequencing (NGS) was carried out to detect potential variant, and the result was verified by Sanger sequencing.
RESULTS:
The patient was found to harbor a heterozygous c.1053delG (p.Glu352SerfsX10) frameshifting variant of the TSC2 gene. The same variant was not found in his unaffected parents and 100 unrelated healthy controls. Based on the American College of Medical Genetics and Genomics guidelines, the variant was predicted to be pathogenic (PVS1+PS2+PM2).
CONCLUSION
The novel c.1053delG (p.Glu352SerfsX10) frameshifting variant of the TSC2 gene probably underlay the TSC in this patient.
Genomics
;
Heterozygote
;
Humans
;
Mutation
;
Tuberous Sclerosis/genetics*
;
Tuberous Sclerosis Complex 2 Protein/genetics*
8.Histopathological and clinical analysis of 150 cases of dermatofibroma
Qinglian LU ; Yeqiang LIU ; Fei OUYANG ; Lingli DENG ; Linli LIU ; Jun MENG
Chinese Journal of Dermatology 2020;53(3):201-205
Objective To analyze histopathological and clinical features of dermatofibroma,and to explore the relationship between them.Methods Clinical and histopathological data were collected from 150 patients with histopathologically confirmed dermatofibroma in Department of Pathology,Shanghai Skin Disease Hospital from September 2017 to August 2018,and analyzed retrospectively.Results Among the 150 patients,65 were males,and 85 were females.Their age was 42 ± 13.8 years,and the course of disease ranged from 3 months to 30 years.Some of the patients had concomitant symptoms,mainly manifesting as itching,some had spontaneous pain and mild tenderness,and 18 patients had a history of injury,insect bite or infection at lesion sites.Skin lesions mainly occurred on the extremities (107 cases,71.3%),and most were solitary (105 cases,70%).Before pathological examinations,102 cases were clinically diagnosed as dermatofibroma,16 as epidermoid cyst,13 as pigmented nevus,3 as keloid,12 as skin mass,1 as malignant melanoma,1 as xanthogranuloma,1 as prurigo nodularis,and 1 as neurofibroma.Among 169 hematoxylin and eosin (HE)-stained sections,25 (14.8%) appeared to be consistent with aneurysmal dermatofibroma,66 (39.1%)with cellular dermatofibroma,36 (21.3%) with sclerosing dermatofibroma,and 22 (13.0%)with epithelioid dermatofibroma.Coexistence of two or more subtypes could be seen in 12 sections.There were also a few new variants,such as dermatofibroma with hyperplastic sweat duct (1 case),deep dermatofibroma (3 cases),dermatofibroma with epithelioid cells intermingled with hyperplastic collagen (1 case).The duration of aneurysmal dermatofibroma varied from 7 months to 30 years,and most manifested as skin masses on the lower extremities.A relatively short course of disease was observed in patients with cellular dermatofibroma,who often visited a hospital several months after the onset,and cellular dermatofibroma was commonly observed on the extremities and frequently accompanied with itching and pain.The duration of sclerosing or atrophic dermatofibroma was usually long for years or decades,and it commonly occurred on the upper limbs without concomitant symptoms.Epithelioid dermatofibroma of varied durations had various clinical manifestations,frequently occurred on the lower limbs without concomitant symptoms.Conclusions The clinical and pathological manifestations of dermatofibroma are diverse.Different dermatofibroma lesions can share similar typical histopathological manifestations,and atypical pathological features can interfere with the diagnosis of dermatofibroma.
9.Clinical study of intensity-modulated radiation therapy combined with chemotherapy in advanced cervical cancer
Qinglian ZHAO ; Shuai ZHANG ; Xinxin LIU ; Wenjie XIE ; Wenbin ZHANG
Journal of Chinese Physician 2018;20(2):243-246
Objective To explore the clinical efficacy of intensity-modulated radiotherapy combined with chemotherapy in the treatment of advanced cervical cancer.Methods All 121 patients with advanced cervical cancer (stage Ⅱ B &Ⅲ A & Ⅲ B) selected in our hospital from June 2012 to June 2014, who were treated with combined chemoradiotherapy, were divided into observation group [intensity modulated radiation therapy (IMRT)group)] and control group [3-dimensional conformal radiation therapy (3D-CRT) group].There was no significant difference between two groups in mean age, body mass index, International Federation of Gynecology and Obstetrics (FIGO) clinical stage, pathological type and chemotherapy mode (P > 0.05).The clinical features of two groups were compared.The treatment and follow-up of two groups were recorded.Results The bone marrow suppression [32.2% (19/59) vs 51.6% (32/ 62)], gastrointestinal reaction [42.4% (25/59) vs 62.9% (39/62)], and rectal reaction rate [27.1% (16/59) vs 45.2% (28/62)] of the observation group were significantly less than that of the control group (P < 0.05).The incidences of genitourinary tract injury [18.6% (11/59) vs 24.2% (15/62)], radiation proctitis [23.7% (i4/59) vs 25.8% (16/62)] and radiation cystitis [16.9% (10/59) vs 20.9% (13/ 62)] of two groups had no significant difference (P > 0.05).Two groups were followed up for 3 years, the local control rate of the observation group was significantly higher than that of the control group (86.3% vs 70.1%) (P < 0.05).Conclusions IMRT combined with chemotherapy in the treatment of advanced cer vical cancer can improve the local control rate of tumor, protect the endangered organ, and reduce the side effects of radiotherapy.
10.Bibliometrics and visualization analysis of research papers on Ethical Review of drug clinical trials in China
Ji ZHANG ; Jia XU ; Yan HUANG ; Qinglian LIU
Chinese Journal of Medical Science Research Management 2021;34(5):387-392
Objective:To better understand the development of domestic drug clinical trial ethical review related research, and provide possible reference for future studies.Methods:The data were searched and extracted from the databases such as CNKI, WANFANG. Research Papers on Ethical Review of drug clinical trials in China from 2003 to 2020 were reviewed. Bibliometric and visualization method was used to analyze the number of publications, journal categories, authors, key words, et al.Results:336 papers were selected according to the criteria. The number of published papers was increasing slowly during the years. These papers were published in 107 journals, authors from the Affiliated Hospital of Nanjing University of Chinese Medicine participated in the largest publications. Beijing, Jiangsu and Shanghai ranked among the top three in terms of papers published by medical and scientific research institutions. The largest numbers of such paper were published in Chinese Journal of Medical Ethics (53). The most collaborative authors were Xiong Ningning, Liu Haitao, Lu Qi, Wang Xiuqin, Wu Cuiyun. The research hotspots were human subject protection, post-approval management, multi-center clinical trials, pregnant participant, clinical trials involving children, Good Clinical Practice and COVID-19 in recent years. There were about 11 kinds of research funding from provincial level and higher. Conclusions:It is helpful for researchers to understand the knowledge structures, latest progress, seeking for cooperation and communication, improvement and paper submission in their fields of ethical review through bibliometrics and visualization analysis.